Fertility and Sterility
Volume 94, Issue 4 , Pages 1202-1207 , September 2010

Reproducibility of the interpretation of pelvic x-ray 3 months after hysteroscopic sterilization with Essure

  • Sebastiaan Veersema, M.D.

      Affiliations

    • St. Antonius Hospital, Nieuwegein, the Netherlands
    • Corresponding Author InformationReprint requests: Sebastiaan Veersema, M.D., Koperwiekweg 34, 3403 ZS IJsselstein, the Netherlands (FAX: + 31-30-6874669).
    • ,
  • Ben W.J. Mol, M.D., Ph.D.

      Affiliations

    • Academic Medical Centre, Amsterdam, the Netherlands
    • ,
  • Hans A.M. Brölmann, M.D., Ph.D.

      Affiliations

    • VU University Medical Center, Amsterdam, the Netherlands

Received 23 September 2008 ,Revised 10 May 2009 ,Accepted 11 May 2009.

References 

  1. Kerin JF, Cooper JM, Price T, Van Herendael BJ, Cayuela-Font E, Cher D, et al. Hysteroscopic sterilization using a micro-insert device: results of a multicentre phase II study. Hum Reprod. 2003;18:1223–1230
  2. Kerin JF, Munday DN, Ritossa MG, Pesce A, Rosen D. Essure hysteroscopic sterilization: results based on utilizing a new coil catheter delivery system. J Am Assoc Gynecol Laparosc. 2004;11:388–393
  3. Cooper JM, Carignan CS, Cher D, Kerin JF. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol. 2003;102:59–67
  4. Valle RF, Carignan CS, Wright TC. Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study. Fertil Steril. 2001;76:974–980
  5. Conceptus . Physician training manual. San Carlos, CA: Conceptus; 2003;
  6. Ubeda A, Labastida R, Dexeus S. Essure: a new device for hysteroscopic tubal sterilization in an outpatient setting. Fertil Steril. 2004;82:196–199
  7. Heredia F, Cos R, Moros S, Torrabadella L, Cayuela E. Radiological control of Essure placements. Gynecol Surg. 2004;1:201–203
  8. Arjona JE, Miño M, Cordón J, Povedano B, Pelegrin B, Castelo-Branco C. Satisfaction and tolerance with office hysteroscopic tubal sterilization. Fertil Steril. 2008;90:1182–1186
  9. Gerritse MB, Veersema S, Timmermans A, Brölmann HA. Incorrect position of Essure microinserts, 3 months after successful bilateral placement. Fertil Steril. 2009;91:930–934
  10. Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. 3rd ed. New York: Wiley; 2003;
  11. Litta P, Cosmi E, Sacco G, Saccardi C, Ciavattini A, Ambrosini G. Hysteroscopic permanent tubal sterilization using a nitinol-Dacron intratubal device without anaesthesia in the outpatient setting: procedure feasibility and effectiveness. Hum Reprod. 2005;20:3419–3422
  12. van der Leij G, Lammes FB. Radiographic aspects of office hysteroscopic tubal occlusion with siloxane intratubal devices (the Ovabloc method). Int J Gynaecol Obstet. 1997;59:123–131
  13. Kerin JF, Levy BS. Ultrasound: an effective method for localization of the echogenic Essure sterilization micro-insert: correlation with radiologic evaluations. J Minim Invasive Gynecol. 2005;12:50–54
  14. Teoh M, Meagher S, Kovacs G. Ultrasound detection of the Essure permanent birth control device: a case series. Aus NZ J Obstet. 2003;43:378–380
  15. Veersema S, Vleugels MP, Timmermans A, Brolmann HA. Follow-up of successful bilateral placement of Essure microinserts with ultrasound. Fertil Steril. 2005;84:1733–1736
  16. Weston G, Bowditch J. Office ultrasound should be the first-line investigation for confirmation of correct Essure placement. Aus NZ J Obstet Gynaecol. 2005;45:312–315
  17. Thiel JA, Suchet IB, Lortie K. Confirmation of Essure microinsert tubal coil placement with conventional and volume-contrast imaging three-dimensional ultrasound. Fertil Steril. 2005;84:504–508

 S.V. is a consultant for Conceptus SAS and a member of the advisory board for Hologic Inc. B.W.J.M. has nothing to disclose. H.A.M.B. has nothing to disclose.

PII: S0015-0282(09)01099-1

doi: 10.1016/j.fertnstert.2009.05.023

Fertility and Sterility
Volume 94, Issue 4 , Pages 1202-1207 , September 2010

Article Tools

* Image Usage & Resolution